Velligan DI - Search Results

1

The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings.

Velligan DI, Prihoda TJ, Sui D, Ritch JL, Maples N, Miller AL. Velligan DI, et al. J Clin Psychiatry. 2003 May;64(5):524-31. doi: 10.4088/jcp.v64n0505. J Clin Psychiatry. 2003. PMID: 12755654 Clinical Trial.

2

Negative symptoms of schizophrenia: where do we go from here?

Miller AL, Mahurin RK, Velligan DI, Maas JW. Miller AL, et al. Among authors: velligan di. Biol Psychiatry. 1995 May 15;37(10):691-3. doi: 10.1016/0006-3223(95)00021-8. Biol Psychiatry. 1995. PMID: 7640323 No abstract available.

3

Validity of the Allen Cognitive Levels Assessment: a tri-ethnic comparison.

Velligan DI, True JE, Lefton RS, Moore TC, Flores CV. Velligan DI, et al. Psychiatry Res. 1995 Mar 27;56(2):101-9. doi: 10.1016/0165-1781(95)02532-7. Psychiatry Res. 1995. PMID: 7667435

4

Longitudinal analysis of communication deviance in the families of schizophrenic patients.

Velligan DI, Funderburg LG, Giesecke SL, Miller AL. Velligan DI, et al. Psychiatry. 1995 Feb;58(1):6-19. doi: 10.1080/00332747.1995.11024707. Psychiatry. 1995. PMID: 7792324

5

Preliminary evaluation of cognitive adaptation training to compensate for cognitive deficits in schizophrenia.

Velligan DI, Mahurin RK, True JE, Lefton RS, Flores CV. Velligan DI, et al. Psychiatr Serv. 1996 Apr;47(4):415-7. doi: 10.1176/ps.47.4.415. Psychiatr Serv. 1996. PMID: 8689375

6

The relationship between parental communication deviance and relapse in schizophrenic patients in the 1-year period after hospital discharge. A pilot study.

Velligan DI, Miller AL, Eckert SL, Funderburg LG, True JE, Mahurin RK, Diamond P, Hazelton BC. Velligan DI, et al. J Nerv Ment Dis. 1996 Aug;184(8):490-6. doi: 10.1097/00005053-199608000-00006. J Nerv Ment Dis. 1996. PMID: 8752078

7

Clonidine plus haloperidol in the treatment of schizophrenia/psychosis.

Maas JW, Miller AL, Tekell JL, Funderburg L, Silva JA, True J, Velligan D, Berman N, Bowden CL. Maas JW, et al. J Clin Psychopharmacol. 1995 Oct;15(5):361-4. doi: 10.1097/00004714-199510000-00009. J Clin Psychopharmacol. 1995. PMID: 8830068 Clinical Trial.

8

A comparison of instrument sensitivity to negative symptom change.

Eckert SL, Diamond PM, Miller AL, Velligan DI, Funderburg LG, True JE. Eckert SL, et al. Among authors: velligan di. Psychiatry Res. 1996 Jun 26;63(1):67-75. doi: 10.1016/0165-1781(96)02870-3. Psychiatry Res. 1996. PMID: 8832775

9

Relationship between specific types of communication deviance and attentional performance in patients with schizophrenia.

Velligan DI, Mahurin RK, Eckert SL, Hazleton BC, Miller A. Velligan DI, et al. Psychiatry Res. 1997 Apr 18;70(1):9-20. doi: 10.1016/s0165-1781(97)03067-9. Psychiatry Res. 1997. PMID: 9172273

10

The functional significance of symptomatology and cognitive function in schizophrenia.

Velligan DI, Mahurin RK, Diamond PL, Hazleton BC, Eckert SL, Miller AL. Velligan DI, et al. Schizophr Res. 1997 May 3;25(1):21-31. doi: 10.1016/S0920-9964(97)00010-8. Schizophr Res. 1997. PMID: 9176924

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters